Myomo (NYSEAMERICAN:MYO) Insider Sells $20,464.00 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Harry Kovelman sold 20,464 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $1.00, for a total value of $20,464.00. Following the completion of the transaction, the insider owned 120,154 shares of the company’s stock, valued at $120,154. This trade represents a 14.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Harry Kovelman also recently made the following trade(s):

• On Thursday, May 28th, Harry Kovelman sold 11,536 shares of Myomo stock. The stock was sold at an average price of $1.02, for a total value of $11,766.72.

Myomo Trading Up 9.0%

MYO stock opened at $1.09 on Friday. The company has a current ratio of 2.73, a quick ratio of 2.36 and a debt-to-equity ratio of 1.21. Myomo, Inc. has a 12-month low of $0.61 and a 12-month high of $3.14. The stock has a market cap of $42.12 million, a price-to-earnings ratio of -3.03 and a beta of 1.39. The business’s 50-day moving average is $0.81 and its 200 day moving average is $0.85.

Analyst Ratings Changes

Separately, Craig Hallum reiterated a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $7.67.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Lazard Asset Management LLC acquired a new position in shares of Myomo during the 2nd quarter worth approximately $98,000. Engineers Gate Manager LP raised its position in shares of Myomo by 62.8% during the 2nd quarter. Engineers Gate Manager LP now owns 30,097 shares of the company’s stock valued at $65,000 after buying an additional 11,614 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Myomo during the 2nd quarter valued at approximately $38,000. New York State Common Retirement Fund purchased a new stake in shares of Myomo during the 2nd quarter valued at approximately $97,000. Finally, XTX Topco Ltd purchased a new stake in shares of Myomo during the 2nd quarter valued at approximately $134,000. 44.99% of the stock is currently owned by institutional investors and hedge funds.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.